Given the emerging role of cuproptosis in cancer therapeutic strategies and the relationship between SNHG26 and cuproptosis in CRC [18], we investigated whether SNHG26 modulates the sensitivity of CRC cells to this novel cell death pathway. Here, SNHG26 is linked to colorectal carcinoma.